Subcutaneous administration of brain natriuretic peptide in experimental heart failure. (Q54029914)

23 May 2018

title

Subcutaneous administration of brain natriuretic peptide in experimental heart failure. (English)

1 reference

23 May 2018

0 references

Chen HH

1

1 reference

23 May 2018

Grantham JA

2

1 reference

23 May 2018

Schirger JA

3

1 reference

23 May 2018

Jougasaki M

4

1 reference

23 May 2018

Redfield MM

5

1 reference

23 May 2018

Burnett JC Jr

6

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 November 2000

1 reference

23 May 2018

Journal of the American College of Cardiology

published in

1 reference

23 May 2018

volume

36

1 reference

23 May 2018

issue

5

1 reference

23 May 2018

page(s)

1706-1712

1 reference

23 May 2018

A new natriuretic peptide in porcine brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Isolation and identification of a high molecular weight brain natriuretic peptide in porcine cardiac atrium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Biochemical detection of left-ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Brain natriuretic peptide: effect on left ventricular filling patterns in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Atrial natriuretic peptide elevation in congestive heart failure in the human

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Effects of brain natriuretic peptide on hemodynamics and renal function in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

The renal action of atrial natriuretic peptide during control of glomerular filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

The role of neutral endopeptidase in dogs with evolving congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900911-6

7 January 2021

10.1016/S0735-1097(00)00911-6

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018